IDO1 and melanoma: The efficacy of TRP2 peptides in generating anti-melanoma immune responses was also tested using a novel microparticle composed of yeast-expressing TRP2 peptide-loaded with PEI/siRNA conjugates for the co-delivery of indoleamine 2,3-dioxygenase (IDO1)-targeting siRNAs.